David Currow
Overview
Explore the profile of David Currow including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
180
Citations
2109
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Smallwood N, Pascoe A, Buchan C, Wong A, Currow D, Le B
Ther Adv Respir Dis
. 2025 Mar;
19:17534666251314722.
PMID: 40071312
Background: High-flow nasal oxygen (HFNO) therapy delivers humidified, heated air with flow rates of up to 60 L/min with oxygen entrained. HFNO has advantages over conventional oxygen therapy, including precise...
2.
Luckett T, Swan F, Clark J, Roberts M, Pearson M, Hutchinson A, et al.
Eur Respir J
. 2025 Feb;
65(2).
PMID: 39915045
No abstract available.
3.
Altree T, Pinczel A, Toson B, Loffler K, Hudson A, Zeng J, et al.
Chest
. 2024 Dec;
PMID: 39675518
Background: Low-dose morphine may be prescribed to reduce chronic breathlessness in COPD. Subjective findings suggest morphine may influence breathlessness through sleep-related mechanisms. However, concerns exist regarding opioid safety in COPD....
4.
Ferreira D, Ekstrom M, Louw S, McCloud P, Johnson M, Clark K, et al.
BMJ Open Respir Res
. 2024 Dec;
11(1.
PMID: 39632100
Introduction: Optimally measuring improvements in chronic breathlessness in clinical practice and research continues to evolve. The aim of this study was to consider the performance of uni-dimensional measures in ....
5.
Mendis R, Wong A, Frenkel S, Southcott A, Selman C, Martin J, et al.
J Palliat Med
. 2024 Sep;
27(10):1368-1373.
PMID: 39304187
Sleep disturbance has a prevalence of 30-78% in patients with advanced cancer. While pharmacotherapy is common, randomized controlled studies (RCTs) investigating available agents are limited. This study examines the efficacy...
6.
Morrell S, Roder D, Currow D, Engel A, Hovey E, Lewis C, et al.
Front Oncol
. 2024 Sep;
14:1338754.
PMID: 39234396
Introduction: Population cancer registries record primary cancer incidence, mortality and survival for whole populations, but not more timely outcomes such as cancer recurrence, secondary cancers or other complications that disrupt...
7.
Luckett T, Phillips J, Agar M, Richards L, Reynolds N, Garcia M, et al.
BMC Health Serv Res
. 2024 Aug;
24(1):969.
PMID: 39174979
Background: The Stop Cancer PAIN Trial was a phase III pragmatic stepped wedge cluster randomised controlled trial which compared effectiveness of screening and guidelines with or without implementation strategies for...
8.
Kochovska S, Ferreira D, Chang S, Brunelli V, Morgan D, Similowski T, et al.
BMJ Open Respir Res
. 2024 Jul;
11(1).
PMID: 39038915
Introduction: Disability, resulting from altered interactions between individuals and their environment, is a worldwide issue causing inequities and suffering. Many diseases associated with breathlessness cause disability but the relationship between...
9.
Gillies M, Chidwick K, Bharat C, Camacho X, Currow D, Gisev N, et al.
Br J Clin Pharmacol
. 2024 May;
90(9):2111-2123.
PMID: 38803009
Aims: The aim of this work is to describe opioid initiation and long-term use after emergency department (ED) visits or hospitalizations in New South Wales, Australia, by patient, admission and...
10.
Kochovska S, Iyer R, Chang S, Ferreira D, Brunelli V, Kinchin I, et al.
PLOS Glob Public Health
. 2024 May;
4(5):e0002655.
PMID: 38696528
There are no known estimates of the prevalence, severity and impacts from breathlessness in low- and middle-income countries. This study aimed to explore the prevalence, severity, self-attributed underlying conditions and...